GNFT
Price
$3.61
Change
+$0.06 (+1.69%)
Updated
Sep 29, 01:23 PM (EDT)
Capitalization
182.52M
52 days until earnings call
ORMP
Price
$2.68
Change
+$0.27 (+11.20%)
Updated
Sep 29, 04:59 PM (EDT)
Capitalization
98.82M
46 days until earnings call
Interact to see
Advertisement

GNFT vs ORMP

Header iconGNFT vs ORMP Comparison
Open Charts GNFT vs ORMPBanner chart's image
Genfit SA
Price$3.61
Change+$0.06 (+1.69%)
Volume$500
Capitalization182.52M
Oramed Pharmaceuticals
Price$2.68
Change+$0.27 (+11.20%)
Volume$4.5K
Capitalization98.82M
GNFT vs ORMP Comparison Chart in %
Loading...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNFT vs. ORMP commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNFT is a StrongBuy and ORMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (GNFT: $3.55 vs. ORMP: $2.41)
Brand notoriety: GNFT and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNFT: 155% vs. ORMP: 36%
Market capitalization -- GNFT: $182.52M vs. ORMP: $98.82M
GNFT [@Biotechnology] is valued at $182.52M. ORMP’s [@Biotechnology] market capitalization is $98.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNFT’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • GNFT’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than GNFT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNFT’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 6 bullish TA indicator(s).

  • GNFT’s TA Score: 5 bullish, 6 bearish.
  • ORMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than GNFT.

Price Growth

GNFT (@Biotechnology) experienced а -18.01% price change this week, while ORMP (@Biotechnology) price change was +2.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was +59.53%.

Reported Earning Dates

GNFT is expected to report earnings on Nov 20, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNFT($183M) has a higher market cap than ORMP($98.8M). GNFT has higher P/E ratio than ORMP: GNFT (103.10) vs ORMP (20.91). ORMP YTD gains are higher at: -0.413 vs. GNFT (-4.441).
GNFTORMPGNFT / ORMP
Capitalization183M98.8M185%
EBITDAN/A-22.07M-
Gain YTD-4.441-0.4131,075%
P/E Ratio103.1020.91493%
RevenueN/A2M-
Total CashN/A97.9M-
Total DebtN/A912K-
FUNDAMENTALS RATINGS
GNFT vs ORMP: Fundamental Ratings
GNFT
ORMP
OUTLOOK RATING
1..100
5288
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
8349
P/E GROWTH RATING
1..100
243
SEASONALITY SCORE
1..100
3916

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (52) in the Pharmaceuticals Other industry is in the same range as GNFT (80) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as GNFT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as GNFT (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to GNFT’s over the last 12 months.

ORMP's Price Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for GNFT (83) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than GNFT’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ORMP (43) in the Pharmaceuticals Other industry. This means that GNFT’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNFTORMP
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 6 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
70%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 13 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MUSLF0.040.01
+18.33%
Promino Nutritional Sciences Inc.
ABMRF32.651.53
+4.90%
ABN Amro Group NV
BVSFF1.15N/A
N/A
Bravura Solutions Ltd.
TRBRF0.57N/A
-0.20%
TRUBAR INC.
NISTF21.55-0.95
-4.22%
Nippon Steel Corporation

GNFT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNFT has been loosely correlated with SPRB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GNFT jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+0.45%
SPRB - GNFT
39%
Loosely correlated
N/A
CVALF - GNFT
25%
Poorly correlated
-4.38%
ORMP - GNFT
25%
Poorly correlated
+0.42%
GLTO - GNFT
25%
Poorly correlated
-0.90%
CAPR - GNFT
24%
Poorly correlated
+8.74%
More